randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als The Scientific and Therapeutic Rationale Off‐Label Treatments in Amyotrophic Lateral Sclerosis - Bedlack - 2025 The Scientific and Therapeutic Rationale
The Scientific and Therapeutic Rationale for OffLabel Treatments in Amyotrophic Lateral Sclerosis Bedlack 2025 Annals of Neurology Wiley Online Library PDF) Acetyl L Carnitine (ALC) in Attention Deficit Hyperactivity Disorder: A Multi Site, Placebo Controlled Pilot Trial Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis ScienceDirect The effects of l Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double blind, randomized, placebo controlled trial Clinical Nutrition ESPEN A randomized double blind placebo controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID 19 ScienceDirect Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study Journal of Neurology, Neurosurgery & Psychiatry
Pay in 4 interest-free payments of $5.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





